Literature DB >> 6686586

Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats.

R W Mast, A R Jeffcoat, B M Sadler, R C Kraska, M A Friedman.   

Abstract

The metabolism, excretion and disposition of melamine were determined after administration of a single oral dose of 0.025 mCi (0.38 mg) [14C]melamine to adult male Fischer 344 rats. Within the first 24 hr, 90% of the administered dose was excreted in the urine. Negligible radioactivity appeared in breath and faeces. There was little difference in blood, liver or plasma concentrations of 14C, suggesting that melamine distributes in body water. The only organs showing radioactivity levels much higher than plasma were the kidney and bladder. The bladder level was by far the highest, a finding probably due either to back diffusion from urine or to contamination of bladder tissue with urine. Virtually no residual radioactivity was observed in tissues examined at 24 hr or later. The elimination-phase half-life calculated from plasma data, 2.7 hr, was in good agreement with the urinary-excretion half-life of 3.0 hr. The renal clearance of melamine was 2.5 ml/min. Radioactivity in plasma or urine co-chromatographed with that of the dosing solution, indicating that melamine is not metabolized in the male Fischer 344 rat.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6686586     DOI: 10.1016/0278-6915(83)90216-8

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  14 in total

1.  Follow-up results of children with melamine induced urolithiasis: a prospective observational cohort study.

Authors:  Jian Gao; Hong Xu; Xin-Yu Kuang; Wen-Yan Huang; Nai-Qing Zhao; Jia Rao; Qiang-Ying Qian; Xian-Ying Cheng; Zhi-Min Feng; Jing Xu; Xin Zhang; Xiang Wang
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Pharmacokinetics of melamine and cyanuric acid and their combinations in F344 rats.

Authors:  Cristina C Jacob; Linda S Von Tungeln; Michelle Vanlandingham; Frederick A Beland; Gonçalo Gamboa da Costa
Journal:  Toxicol Sci       Date:  2012-01-06       Impact factor: 4.849

Review 3.  A Brief Review of Neurotoxicity Induced by Melamine.

Authors:  Lei An; Wei Sun
Journal:  Neurotox Res       Date:  2017-04-13       Impact factor: 3.911

4.  The selective NADPH oxidase inhibitor apocynin has potential prophylactic effects on melamine-related nephrolithiasis in vitro and in vivo.

Authors:  Xiaoran Li; Jianzhong Lu; Panfeng Shang; Junsheng Bao; Zhongjin Yue
Journal:  Mol Cell Biochem       Date:  2014-10-16       Impact factor: 3.396

5.  Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation.

Authors:  Xiuli Lu; Bing Gao; Youliang Wang; Zehui Liu; Takahiro Yasui; Ping Liu; Jian Liu; Newton Emmanuel; Qiwen Zhu; Chunling Xiao
Journal:  Urol Res       Date:  2012-09-28

Review 6.  Melamine toxicity.

Authors:  Carl G Skinner; Jerry D Thomas; John D Osterloh
Journal:  J Med Toxicol       Date:  2010-03

7.  Melamine-contaminated milk products induced urinary tract calculi in children.

Authors:  Li Zhang; Ling-Ling Wu; Ya-Ping Wang; Ai-Min Liu; Chao-Chun Zou; Zheng-Yan Zhao
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

8.  The true stone composition and abnormality of urinary metabolic lithogenic factors of rats fed diets containing melamine.

Authors:  Xiaoming Cong; Xiaojian Gu; Yan Xu; Xizhao Sun; Luming Shen
Journal:  Urolithiasis       Date:  2013-11-28       Impact factor: 3.436

9.  Preventive and therapeutic effects of sodium bicarbonate on melamine-induced bladder stones in mice.

Authors:  Shu-Ting Ren; Yun-Xia Du; Chang-Fu Xu; Jiao-Jiao Zhang; Li-Ping Mo; Ying Sun; Xiao-Li Gao
Journal:  Urolithiasis       Date:  2014-08-05       Impact factor: 3.436

10.  Comparison Impairments of Spatial Cognition and Hippocampal Synaptic Plasticity Between Prenatal and Postnatal Melamine Exposure in Male Adult Rats.

Authors:  Lei An; Tao Zhang
Journal:  Neurotox Res       Date:  2015-11-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.